Guggenheim Reiterates Buy Rating on Acadia Healthcare Company, Inc. (ACHC)

Market Context

Acadia Healthcare Company, Inc. operates in the Healthcare sector. The stock currently trades at $28.14 with a market capitalization of $2.1B. The stock has gained 29.3% over the past 52 weeks.

Analyst coverage from Guggenheim provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Acadia Healthcare Company, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Acadia Healthcare Company, Inc.

Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 30, 2026	Guggenheim	Buy	N/A
Jul 30, 2026	Barclays	Equal-Weight	N/A
Jul 20, 2026	Guggenheim	Buy	N/A
Jul 14, 2026	TD Cowen	Buy	N/A
Jul 14, 2026	Keybanc	Overweight	N/A

Related Tools: Analyst Ratings Dashboard | View ACHC Stock Page